{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:14:08Z","timestamp":1791818048360,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bone.2014.04.032","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T03:00:46Z","timestamp":1402369246000},"page":"72-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Increased fracture callus mineralization and strength in cathepsin K knockout mice"],"prefix":"10.1016","volume":"66","author":[{"given":"Michael A.","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Y.","family":"Soung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlyle","family":"Horrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Samadfam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Drissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le T.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2014.04.032_bb0005","volume":"vol. 66","author":"Kanis","year":"2007"},{"key":"10.1016\/j.bone.2014.04.032_bb0010","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2014.04.032_bb0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinthera.2012.02.002","article-title":"Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.","volume":"34","author":"Dempster","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.bone.2014.04.032_bb0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/07853899309147299","article-title":"Bisphosphonates in the treatment of metabolic bone diseases","volume":"25","author":"Rodan","year":"1993","journal-title":"Ann Med"},{"key":"10.1016\/j.bone.2014.04.032_bb0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.032_bb0030","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/jcb.10435","article-title":"Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation","volume":"88","author":"Gerstenfeld","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2014.04.032_bb0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jor.1100140113","article-title":"Effect of alendronate on fracture healing and bone remodeling in dogs","volume":"14","author":"Peter","year":"1996","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1359\/jbmr.081113","article-title":"Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing","volume":"24","author":"Gerstenfeld","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jbmr.1475","article-title":"Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys","volume":"27","author":"Masarachia","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0050","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jbmr.223","article-title":"Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits","volume":"26","author":"Pennypacker","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.bone.2014.04.032_bb0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bone.2013.06.008","article-title":"Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate","volume":"56","author":"Williams","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.032_bb0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-011-1593-2","article-title":"Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys","volume":"23","author":"Jerome","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2014.04.032_bb0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jbmr.1477","article-title":"Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey","volume":"27","author":"Cusick","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0070","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1359\/jbmr.2001.16.10.1739","article-title":"Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate","volume":"16","author":"Stroup","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0075","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1016\/j.bmcl.2004.05.087","article-title":"Rational design of potent and selective NH-linked aryl\/heteroaryl cathepsin K inhibitors","volume":"14","author":"Robichaud","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bone.2014.04.032_bb0080","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.bmcl.2007.12.047","article-title":"The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K","volume":"18","author":"Gauthier","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"10.1016\/j.bone.2014.04.032_bb0085","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.1695","article-title":"Odanacatib in the treatment of postmenopausal women with low bone mineral density: 5years of continued therapy in a phase 2 study","volume":"27","author":"Langdahl","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bone.2008.08.130","article-title":"Bone density, strength, and formation in adult cathepsin K (\u2212\/\u2212) mice","volume":"44","author":"Pennypacker","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.032_bb0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/0-306-46826-3_32","article-title":"Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice","volume":"477","author":"Saftig","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bone.2014.04.032_bb0100","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","article-title":"Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice","volume":"95","author":"Saftig","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2014.04.032_bb0105","first-page":"666","article-title":"Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation","volume":"123","author":"Lotinun","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.04.032_bb0110","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1359\/jbmr.070724","article-title":"Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures","volume":"22","author":"Kakar","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jbmr.185","article-title":"Fracture healing is accelerated in the absence of the adaptive immune system","volume":"26","author":"Toben","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jor.1100020115","article-title":"Production of a standard closed fracture in laboratory animal bone","volume":"2","author":"Bonnarens","year":"1984","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0125","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/jbmr.1601","article-title":"Runx1 dose-dependently regulates endochondral ossification during skeletal development and fracture healing","volume":"27","author":"Soung Do","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bone.2013.02.010","article-title":"Effects of pharmacological inhibition of cathepsin K on fracture repair in mice","volume":"55","author":"Soung Do","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.032_bb0135","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0140","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1210\/endo.139.3.5831","article-title":"The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats","volume":"139","author":"Yamamoto","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.04.032_bb0145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1172\/JCI5244","article-title":"Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein","volume":"103","author":"Safadi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.04.032_bb0150","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0155","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1359\/JBMR.050702","article-title":"Application of histomorphometric methods to the study of bone repair","volume":"20","author":"Gerstenfeld","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0160","series-title":"Animal Models in Orthopaedic Research","first-page":"197","article-title":"Animal models of bone fracture or osteotomy","author":"An","year":"1999"},{"key":"10.1016\/j.bone.2014.04.032_bb0165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/17453670510041439","article-title":"Cyclooxygenase-2 inhibitor delays fracture healing in rats","volume":"76","author":"Endo","year":"2005","journal-title":"Acta Orthop"},{"key":"10.1016\/j.bone.2014.04.032_bb0170","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.bone.2008.05.010","article-title":"The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice","volume":"44","author":"Yamane","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.032_bb0175","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jbmr.212","article-title":"Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect","volume":"26","author":"Eisman","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.bone.2014.04.032_bb0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bone.2013.02.010","article-title":"Effects of pharmacological inhibition of cathepsin K on fracture repair in mice","volume":"55","author":"Soung","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.032_bb0185","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1021\/jm0504961","article-title":"Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity","volume":"48","author":"Falgueyret","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bone.2014.04.032_bb0190","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/ar3839","article-title":"Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage","volume":"14","author":"Dejica","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bone.2014.04.032_bb0195","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2353\/ajpath.2008.070494","article-title":"Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage","volume":"173","author":"Dejica","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bone.2014.04.032_bb0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002230001152","article-title":"Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus","volume":"67","author":"Uusitalo","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2014.04.032_bb0205","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2006.07.015","article-title":"A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys","volume":"40","author":"Kumar","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.032_bb0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/clpt.2009.60","article-title":"Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies","volume":"86","author":"Stoch","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bone.2014.04.032_bb0215","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bone.2004.09.020","article-title":"Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL\/OPG ratio","volume":"36","author":"Kiviranta","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.032_bb0220","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bone.2011.06.014","article-title":"The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking","volume":"49","author":"Leung","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.032_bb0225","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1359\/jbmr.060313","article-title":"Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass","volume":"21","author":"Li","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0230","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.106.102798","article-title":"An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats","volume":"318","author":"Kim","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bone.2014.04.032_bb0235","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bone.2013.01.003","article-title":"Cellular and molecular mechanisms of accelerated fracture healing by COX2 gene therapy: studies in a mouse model of multiple fractures","volume":"53","author":"Lau","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.032_bb0240","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jbmr.2040","article-title":"Inhibition of miR-92a enhances fracture healing via promoting angiogenesis in a model of stabilized fracture in young mice","volume":"29","author":"Murata","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1359\/jbmr.081002","article-title":"Reduced COX-2 expression in aged mice is associated with impaired fracture healing","volume":"24","author":"Naik","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.032_bb0250","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00223-002-2092-4","article-title":"Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts","volume":"73","author":"Everts","year":"2003","journal-title":"Calcif Tissue Int"}],"updated-by":[{"DOI":"10.1016\/j.bone.2014.08.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000}}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:38:44Z","timestamp":1757612324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":50,"alternative-id":["S8756328214002014"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.04.032","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bone.2014.08.012","asserted-by":"object"}]},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased fracture callus mineralization and strength in cathepsin K knockout mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.04.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}